CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 104 enrolled
Drug / intervention
Benzyl Benzoate 25% Topical Application Lotiondrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04205669
NCT04205669Phase 4Completed

A Randomized Controlled Trial Comparing the Effectiveness of Individual vs. Household Treatment for Scabies in Lambaréné, Gabon

Centre de Recherche Médicale de Lambaréné·interventional·Posted Dec 19, 2019·Updated Nov 13, 2020

In Brief

A Phase 4 clinical trial evaluating Benzyl Benzoate 25% Topical Application Lotion for Scabies and Households. Completed, enrolled 104 participants across 1 site.

Detailed Summary

It is unclear whether individual treatment of scabies is similarly effective compared to household treatment. This study therefore compares these two treatment strategies with topical benzyl benzoate for treating scabies in Lambaréné and surroundings in Gabon. Subjects presenting with uncomplicated scabies are randomized into either the Individual Treatment group, where only the affected subjects receive treatment, or the Household Treatment group, where all family members are treated in parallel to the affected subjects regardless of signs and symptoms. The primary endpoint is clinical cure after 28 days; the secondary endpoint is the proportion of affected household members per household after 28 days.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsScabies, Households
CountriesGabon

Timeline

Phase 4CompletedFinished
20192020202120222023202420252026
First PostedDec 19, 2019
Enrollment StartOct 4, 2018
Primary CompletionFeb 21, 2019
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 6.5 years ago

Interventions

Benzyl Benzoate 25% Topical Application Lotiondrug

Applied to skin for the treatment of scabies